home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Global Pharmaceutical Research & Development Summit

 
  July 18, 2006  
     
 
World Trade Group Toronto, Anaheim, California
23rd - 25th October 2006


Hosting over 300 of the world’s leading pharmaceutical professionals, the 3rd Annual Pharma Research & Development Summit provides a unique opportunity to network and do business with industry peers.

Pharma R&D 2006 features case studies from the world’s leading pharmaceutical companies focusing on overcoming scientific and strategic challenges faced in the research and development process.

Key topics to be discussed at the Global Pharma R&D Summit 2006:
- FDA– hear about the future role of the FDA
- Pandemics – how to bridge the gap in vaccine and drug access
- Personalized Medicine – how close is it to become a reality?
- Biomarkers – are biomarkers really the holy grail of drug discovery?
- Nanobiotechnology – current status and what research is supported
- Technology – what is the future of R&D technology and where is it leading?

Who should attend Global Pharmaceutical R&D Summit 2006:

Vice Presidents, Directors, Heads of responsible for:

- R&D
- Discovery
- Development
- Preclinical Development
- Screening
- Research
- Pharmaceutical Development
- Informatics Toxicology
- Product Development
- Safety
- Technology
- Chemistry
- Genetics
- Biology

Pre-Arranged Meetings

This is a dedicated session which allows you to take up to 14 pre-scheduled business meetings with fellow leading supplier companies. You will meet with people who you have chosen and who have expressed a strong interest in meeting with you. Selections are made prior to the event using the event catalog which contains detailed information on all participants including short and long-term business objectives. Pre-arranged meetings ensures your networking time is spent productively - maximizing your chance of doing real business at the event

 
 
Organized by: World Trade Group
Invited Speakers: - Dr. Andrew von Eschenbach
Acting Head
Food and Drug Administration
- Dr. Edward Abrahams
Executive Director
Personalized Medicine Coalition
- Dr. Ian MacLachlan
Chief Scientific Officer
Protiva Biotherapeutics Inc
- Dr. Arthur Horwich
Higgins Professor of Genetics and Pediatrics
Yale School of Medicine
- Dr. Berta Strulovici
Vice-President Research, Automated Biotechnology Dept.
Merck & Co.
- Dr. Sunney Xie
Professor of Chemistry and Chemical Biology
Harvard University
- Mark Barbato
Vice President, Alliance Management, Eli Lilly and Company
Eli Lilly and Company
- Dr. John Ardalan
Vice President Worldwide IT Architecture and Infrastructure
Serono
- Dr. Mahdi Fawzi
Executive Vice President, Preclinical Development
Wyeth Research
- Dr. Claudio Carini
Global Head of Biomarkers
Hoffman-La Roche
- Dr. Jim Bristol
Senior Vice President, Worldwide Discovery
Pfizer
- Dr. Frederick Hall
President and CEO
Epeius Biotechnologies Corporation
 
Deadline for Abstracts: none
 
Registration: http://www.rdna.worldtradeco.com/delegate_reg1.asp
E-mail: Lisa.Wulf@worldtradeco.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.